These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31485993)

  • 21. Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease.
    Mendes-Pinheiro B; Teixeira FG; Anjo SI; Manadas B; Behie LA; Salgado AJ
    Stem Cells Transl Med; 2018 Nov; 7(11):829-838. PubMed ID: 30238668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zebrafish for Personalized Regenerative Medicine; A More Predictive Humanized Model of Endocrine Disease.
    Arjmand B; Tayanloo-Beik A; Foroughi Heravani N; Alaei S; Payab M; Alavi-Moghadam S; Goodarzi P; Gholami M; Larijani B
    Front Endocrinol (Lausanne); 2020; 11():396. PubMed ID: 32765420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.
    Broderick PA; Wenning L; Li YS
    J Neural Transm (Vienna); 2017 Jan; 124(1):57-78. PubMed ID: 27796511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cell Replacement Therapy in Parkinson's Disease-History of Development and Prospects for Use in Clinical Practice].
    Katolikova NV; Malashicheva AB; Gainetdinov RR
    Mol Biol (Mosk); 2020; 54(6):939-954. PubMed ID: 33276357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease.
    Rodriguez-Pallares J; Rodriguez-Perez AI; Muñoz A; Parga JA; Toledo-Aral JJ; Labandeira-Garcia JL
    Stem Cells Transl Med; 2016 Jun; 5(6):804-15. PubMed ID: 27075764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy for Parkinson's disease: current status and future potential.
    Segovia J
    Am J Pharmacogenomics; 2002; 2(2):135-46. PubMed ID: 12083948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regenerative effects of peptide nanofibers in an experimental model of Parkinson's disease.
    Sever M; Turkyilmaz M; Sevinc C; Cakir A; Ocalan B; Cansev M; Guler MO; Tekinay AB
    Acta Biomater; 2016 Dec; 46():79-90. PubMed ID: 27619838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular models for Parkinson's disease.
    Falkenburger BH; Saridaki T; Dinter E
    J Neurochem; 2016 Oct; 139 Suppl 1():121-130. PubMed ID: 27091001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase IIb, randomised, double-blind, placebo-controlled, dose-ranging investigation of the safety and efficacy of NTCELL
    Snow B; Mulroy E; Bok A; Simpson M; Smith A; Taylor K; Lockhart M; Lam BJ; Frampton C; Schweder P; Chen B; Finucane G; McMahon A; Macdonald L
    Parkinsonism Relat Disord; 2019 Apr; 61():88-93. PubMed ID: 30503748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical and Genetic Zebrafish Models to Define Mechanisms of and Treatments for Dopaminergic Neurodegeneration.
    Wasel O; Freeman JL
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic potential of pluripotent stem cell-derived dopaminergic progenitors in Parkinson's disease: a systematic review protocol.
    Karimi A; Elmi M; Shiri Z; Baharvand H
    Syst Rev; 2021 Jun; 10(1):188. PubMed ID: 34172098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.
    Dinov ID; Heavner B; Tang M; Glusman G; Chard K; Darcy M; Madduri R; Pa J; Spino C; Kesselman C; Foster I; Deutsch EW; Price ND; Van Horn JD; Ames J; Clark K; Hood L; Hampstead BM; Dauer W; Toga AW
    PLoS One; 2016; 11(8):e0157077. PubMed ID: 27494614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
    Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
    Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
    Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
    Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell replacement therapy for Parkinson's disease: how close are we to the clinic?
    Ganz J; Lev N; Melamed E; Offen D
    Expert Rev Neurother; 2011 Sep; 11(9):1325-39. PubMed ID: 21864078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease.
    Salama M; Ellaithy A; Helmy B; El-Gamal M; Tantawy D; Mohamed M; Sheashaa H; Sobh M; Arias-Carrión O
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):836-43. PubMed ID: 23198691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinson's disease: Mechanisms, translational models and management strategies.
    Raza C; Anjum R; Shakeel NUA
    Life Sci; 2019 Jun; 226():77-90. PubMed ID: 30980848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell treatment for Parkinson's disease: an update for 2005.
    Snyder BJ; Olanow CW
    Curr Opin Neurol; 2005 Aug; 18(4):376-85. PubMed ID: 16003112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson's disease.
    Grow DA; McCarrey JR; Navara CS
    Stem Cell Res; 2016 Sep; 17(2):352-366. PubMed ID: 27622596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.